Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
about
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy
P2860
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenetics Biomarkers an ...... udy on Rectal Cancer Patients.
@en
Pharmacogenetics Biomarkers an ...... udy on Rectal Cancer Patients.
@nl
type
label
Pharmacogenetics Biomarkers an ...... udy on Rectal Cancer Patients.
@en
Pharmacogenetics Biomarkers an ...... udy on Rectal Cancer Patients.
@nl
prefLabel
Pharmacogenetics Biomarkers an ...... udy on Rectal Cancer Patients.
@en
Pharmacogenetics Biomarkers an ...... udy on Rectal Cancer Patients.
@nl
P2093
P2860
P50
P356
P1476
Pharmacogenetics Biomarkers an ...... tudy on Rectal Cancer Patients
@en
P2093
Angela Buonadonna
Antonino De Paoli
Caterina Boso
Claudio Belluco
P2860
P356
10.3390/IJMS17091482
P407
P50
P577
2016-09-05T00:00:00Z